J. D. Burton, R. N. Bamford, C. Peters, A. J. Grant, G. Kurys et al., A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells, Proc. Natl. Acad. Sci, vol.91, pp.4935-4939, 1994.

A. Ma, R. Koka, and P. Burkett, Diverse Functions of Il-2, Il-15, And Il-7 In Lymphoid Homeostasis, Annu. Rev. Immunol, vol.24, pp.657-679, 2006.

W. Liao, J. Lin, and W. Leonard, IL-2 Family Cytokines: New Insights into the Complex Roles of IL-2 as a Broad Regulator of T helper Cell Differentiation, Curr. Opin. Immunol, vol.23, pp.598-604, 2011.

J. Marks-konczalik, S. Dubois, J. M. Losi, H. Sabzevari, N. Yamada et al., IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice, Proc. Natl. Acad. Sci, vol.97, pp.11445-11450, 2000.

C. C. Ku, M. Murakami, A. Sakamato, J. Kappler, and P. Marrack, Control of homeostasis of CD8(+) memory T cells by opposing cytokines, Science, vol.288, pp.675-678, 2000.

T. A. Waldmann, The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design, Nat. Rev. Immunol, vol.6, pp.595-601, 2006.

E. Van-de-vosse and M. A. Van-agtmael, Targets of anticytokine therapy and the risk of infections in humans and mice, Curr. Opin. Rheumatol, vol.19, pp.626-635, 2007.

J. A. Johnston, C. M. Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan et al., Tyrosine Phosphorylation and Activation of Stat5, Stat3, And Janus Kinases by Interleukin-2 And Interleukin-15, Proc. Natl. Acad. Sci, vol.92, pp.8705-8709, 1995.

W. Xq, M. Orchardson, J. Gracie, B. P. Leung, G. Bm et al., The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo, J. Immunol, vol.167, pp.277-282, 2001.

M. Chirifu, C. Hayashi, T. Nakamura, S. Toma, T. Shuto et al., Crystal structure of the IL-15-IL-15R alpha complex, a cytokine-receptor unit presented in trans, Nat. Immunol, vol.8, pp.1001-1007, 2007.

A. M. Ring, J. X. Lin, D. Feng, S. Mitra, M. Rickert et al., Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15, Nat. Immunol, vol.13, 1187.

T. A. Waldmann, Cytokines in Cancer Immunotherapy, Cold Spring Harb. Perspect. Biol, vol.10, 2018.

J. M. Wrangle, A. Patterson, C. B. Johnson, D. J. Neitzke, S. Mehrotra et al., IL-2 and Beyond in Cancer Immunotherapy, J. Interf. Cytokine Res, vol.38, pp.45-68, 2018.

A. M. Davis, S. Stgallay, G. J. Kleywegt, and S. St-gallay, Limitations and lessons in the use of X-ray structural information in drug design, Drug Discov. Today, vol.13, pp.831-841, 2008.

M. Skwarczynska and C. Ottmann, Protein-protein interactions as drug targets, Future Med. Chem, vol.7, pp.2195-2219, 2015.

A. J. Wilson, Inhibition of protein-protein interactions using designed molecules, Chem. Soc. Rev, vol.38, 2009.

O. Schillinger, V. Panwalkar, B. Strodel, and A. J. Dingley, Molecular Dynamics Simulations Reveal Key Roles of the Interleukin-6 Alpha Receptor in the Assembly of the Human Interleukin-6 Receptor Complex, J. Phys. Chem. B, vol.121, pp.8113-8122, 2017.

R. Bobby, P. Robustelli, A. V. Kralicek, M. Mobli, G. F. King et al., Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6, FEBS J, vol.281, pp.2471-2483, 2014.

D. Silva, S. Yu, U. Y. Ulge, J. B. Spangler, K. M. Jude et al., De novo design of potent and selective mimics of IL-2 and IL-15, Nature, vol.565, pp.186-191, 2019.

A. Quéméner, M. Maillasson, L. Arzel, B. Sicard, R. Vomiandry et al., Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization, J. Med. Chem, vol.60, pp.6249-6272, 2017.

B. ?y?y?ska-granica, B. Trzaskowski, S. Niewieczerza?, S. Filipek, O. Zegrocka-stendel et al., Pharmacophore guided discovery of small-molecule interleukin 15 inhibitors, Eur. J. Med. Chem, vol.136, pp.543-547, 2017.

M. P. Jacobson, D. L. Pincus, C. S. Rapp, T. J. Day, B. Honig et al., A Hierarchical Approach to All-Atom Protein Loop Prediction, Proteins Struct. Funct. Bioinformat, vol.55, pp.351-367, 2004.

J. C. Phillips, R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid et al., Scalable Molecular Dynamics with NAMD, J. Comput. Chem, vol.26, pp.1781-1802, 2005.

B. R. Brooks, C. L. Brooks, A. D. Iii;-mackerell, . Jr, L. Nilsson et al., The biomolecular simulation program, J. Comput. Chem, vol.30, pp.1545-1614, 2009.

J. Huang and A. D. Mackerell, CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data, J. Comput. Chem, vol.34, pp.2135-2145, 2013.

J. Chandrasekhar, R. W. Impey, W. L. Jorgensen, J. D. Madura, and M. L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys, p.926, 1983.

T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems, J. Chem. Phys, vol.98, pp.10089-10092, 1993.

W. Humphrey, A. Dalke, and K. Schulten, VMD: Visual molecular dynamics, J. Mol. Graph, vol.14, pp.33-38, 1996.

, The Amber Home Page, 2019.

L. Stella and S. Melchionna, Equilibration and sampling in molecular dynamics simulations of biomolecules, J. Chem. Phys, vol.109, pp.10115-10117, 1998.

D. M. Anderson, S. Kumaki, M. Ahdieh, J. Bertles, M. Tometsko et al., Functional Characterization of the Human Interleukin-15 Receptor ?Chain and Close Linkage of IL15RA and IL2RA Genes, J. Biol. Chem, vol.270, pp.29862-29869, 1995.

S. Sakamoto, J. M. Caaveiro, E. Sano, Y. Tanaka, M. Kudou et al., Contributions of Interfacial Residues of Human Interleukin15 to the Specificity and Affinity for Its Private ?-Receptor, J. Mol. Biol, vol.389, pp.880-894, 2009.

E. Mortier, A. Quéméner, P. Vusio, I. Lorenzen, Y. Boublik et al., Soluble Interleukin-15 Receptor ? (IL-15R?)-sushi as a Selective and Potent Agonist of IL-15 Action through IL-15R?/?: Hyperagonist Il-15·Il-15r? Fusion Proteins, J. Biol. Chem, vol.281, pp.1612-1619, 2006.

J. Bernard, C. Harb, E. Mortier, R. H. Meloen, C. Vermot-desroches et al., Identification of an Interleukin-15? Receptor-binding Site on Human Interleukin-15, J. Biol. Chem, vol.279, pp.24313-24322, 2004.

A. Quéméner, J. Bernard, E. Mortier, A. Plet, Y. Jacques et al., Docking of human interleukin-15 to its specific receptor ? chain: Correlation between molecular modeling and mutagenesis experimental data, Proteins Struct. Funct. Bioinformat, vol.65, pp.623-636, 2006.

T. Chernov-rogan, E. Whitehorn, E. Tate, M. P. Bell, R. W. Barrett et al., Ligand binding kinetics of IL-2 and IL-15 to heteromers formed by extracellular domains of the three IL-2 receptor subunits, Int. Immunol, vol.7, pp.1839-1849, 1995.

C. L. Flemming, S. J. Russell, and M. K. Collins, Mutation of Asp20of human interleukin-2 reveals a dual role of the p55 ? chain of the interleukin-2 receptor, Eur. J. Immunol, vol.23, pp.917-921, 1993.

A. B. Shanafelt, Y. Lin, M. Shanafelt, C. P. Forte, N. Dubois-stringfellow et al., A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo, Nat. Biotechnol, vol.18, pp.1197-1202, 2000.

T. P. Bonnert, Structure-Function Studies of Interleukin 15using Site-specific Mutagenesis, Polyethylene Glycol Conjugation, and Homology Modeling, J. Biol. Chem, vol.272, pp.2312-2318, 1997.

L. Collins, W. H. Tsien, C. Seals, J. Hakimi, D. Weber et al., Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit (p70) of the interleukin 2 receptor, Proc. Natl. Acad. Sci, vol.85, 1988.

X. Q. Wang, M. Rickert, and K. C. Garcia, Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gamma(c) receptors, Science, vol.310, pp.1159-1163, 2005.